Research Collaboration

We welcome collaborations with research groups, clinical teams, and academic institutions worldwide. Tell us about your work and what you have in mind.

Who we work with

πŸ”¬
Research groupsJoint projects, shared datasets, co-supervised students
πŸ₯
Clinical teamsPatient-derived samples, translational studies, clinical trials
πŸ’»
Computational labsMachine learning, imaging analysis, proteomics pipelines
🌍
International networksEU consortium projects, visiting researchers, exchanges
πŸŽ“
Prospective studentsSelf-funded PhD, master’s thesis, visiting rotations

Individual Funding Opportunities

Deadlines and amounts are indicative β€” always verify on the funder’s official website before applying.

Stage
Region
πŸ”¬

Technology Access

Access to ISDoT, our proprietary 3D ECM scaffold platform and patient-derived organoid pipeline for drug testing and target validation.

🀝

Collaborative Research

Joint research programmes on tumour microenvironment, metastasis biology, precision oncology, and RNA therapeutics.

πŸ“‹

Contract Research & Consulting

Tailored experimental services, expert consultation on ECM biology, metastasis mechanisms, and preclinical model development.

Industry Enquiry

We partner with biotech and pharma companies across drug discovery, platform licensing, and translational research. Tell us what you’re working on.

Why partner with us

βš—οΈ
Proprietary platformsISDoT and PDO co-culture systems not available elsewhere
πŸ›οΈ
Clinical accessDirect links to Rigshospitalet and UCPH clinical teams
πŸš€
Innovation track record3 spin-outs founded, ERC and NNF funded, active IP portfolio
🌐
EU funding leverageExperienced in Horizon Europe consortium applications
πŸ“©
Direct line to Janine ErlerFor serious enquiries: jerler@bric.ku.dk